da Silva Jorge Santos insider trades: MoonLake Immunotherapeutics (MLTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where da reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | MLTX | ↓ Sell | 150,000 | $18.35 | $2.8M | Direct | Apr 14, 2026 (1d) |
| Dec 9, 2025 | MLTX | ↓ Sell | 200,000 | $14.87 | $3.0M | Direct | Dec 10, 2025 (1d) |
| Feb 29, 2024 | MLTX | ↓ Sell | 123,615 | $55.03 | $6.8M | Direct | Feb 29, 2024 (0d) |
| Feb 21, 2024 | MLTX | ↓ Sell | 1,125 | $55.27 | $62K | Direct | Feb 23, 2024 (2d) |
| Feb 20, 2024 | MLTX | ↓ Sell | 60,000 | $59.26 | $3.6M | Direct | Feb 20, 2024 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MLTX insiders
Open-market trades in the last 12 months
About da Silva Jorge Santos's insider trades
da Silva Jorge Santos is Chief Executive Officer at MoonLake Immunotherapeutics (MLTX). Since Feb 20, 2024, da has reported no open-market purchases and 5 sales worth $16.1M on SEC Form 4. In the last 12 months: 2 sales ($5.7M).
Their filings also include grants and awards (2 filings), conversions (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MLTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.